A Confirmation Study of Eribulin in Combination With Capecitabine

Clinical trial NCT01323530 · COMPLETED

Trial details

NCT number: NCT01323530
Sponsor: Eisai Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2010-01-26
Primary completion: 2014-07-28
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.